Stay updated on Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Sign up to get notified when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.

Latest updates to the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page
- Check2 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry 'Revision: v3.5.0' appears and the previous 'Revision: v3.4.3' entry is removed.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page metadata now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded Revision: v3.4.2 and removed the older notices (including the lapse in government funding notice and Revision: v3.4.1). These are administrative updates and do not affect the study's content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedAdded a general site-wide notice about a lapse in government funding and NIH Clinical Center operations, and updated the site software version to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedUI/metadata updates include showing the glossary and adjusting QC-related labels (e.g., Last Update Submitted that Met QC Criteria). These changes do not affect core study content, eligibility criteria, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.